COLLABORATION AND LICENSE AGREEMENT between POSEIDA THERAPEUTICS, INC. and XYPHOS BIOSCIENCES, INC. April 30, 2024Collaboration and License Agreement • August 5th, 2024 • Poseida Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Research and Collaboration Agreement (this “Agreement”) is made and entered into effective April 30, 2024 (the “Effective Date”) by and between XYPHOS BIOSCIENCES, INC., a Delaware corporation with its principal place of business at 480 Forbes Blvd, South San Francisco, CA 94080, United States (“Xyphos”), and POSEIDA THERAPEUTICS, INC., a Delaware corporation with its principal place of business at 9390 Towne Centre Drive #200, San Diego, CA 92121 (“Poseida”). Xyphos and Poseida are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
